Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Bronchogen, 20mg
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
Bronchogen is a synthetic bioregulatory peptide investigated for its activity in pulmonary tissue models. Research interest centers on its proposed influence on transcriptional regulation associated with inflammatory signalling, epithelial cell maintenance, and surfactant-related pathways. Experimental studies have examined its effects on tissue-specific gene expression, cellular homeostasis, and signalling networks involved in pulmonary tissue function. Research applications include pulmonary bioregulator studies, epithelial signalling research, transcription pathway investigation, and comparative bioregulatory peptide pharmacology.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Chemical Formula | C18H30N4O9 |
|---|---|
| Molar Mass | 446.45 g/mol |
| Total Compound Content | 20mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What pulmonary tissue models are used to study Bronchogen's effects on epithelial maintenance?
Research commonly utilizes bronchial and airway epithelial cell culture models to investigate Bronchogen's effects on epithelial maintenance, barrier integrity, cellular homeostasis, and proliferation-associated pathways. Ex vivo pulmonary tissue cultures are also used to examine tissue-specific responses while preserving native cellular architecture and signalling interactions.
How is Bronchogen's proposed influence on surfactant-related pathways investigated?
Experimental studies frequently employ alveolar epithelial cell models to evaluate surfactant-associated gene expression, protein synthesis, and secretion-related pathways. Common endpoints include measurement of surfactant-related biomarkers, transcriptional activity, and pathway-specific molecular responses following compound exposure.
What research models are used to investigate Bronchogen's role in pulmonary aging and senescence pathways?
Studies examining pulmonary senescence pathways typically utilize aged rodent models and cellular senescence systems to assess biomarkers such as p16INK4a, p21, and senescence-associated β-galactosidase activity. These molecular endpoints are often paired with histological assessment and tissue-architecture analysis to characterize changes in cellular homeostasis and senescence-associated signalling networks.
